Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Van Der AA

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2010
Fibroblast growth factor receptor 3 mutation analysis on voided urine for surveillance of patients with low-grade non-muscle-invasive bladder cancerTahlita C M Zuiverloon, Madelon N M van der Aa, Theo H van der Kwast, et al.
BJU International|September 25, 2007
Patients' perceived burden of cystoscopic and urinary surveillance of bladder cancer: a randomized comparisonMadelon N M van der Aa, Ewout W Steyerberg, E Fatma Sen, et al.
Psycho-Oncology|February 13, 2025
The Prevalence and Associated Factors of Cancer-Related Worries in Adult Survivors of Childhood Cancer: A Systematic ReviewAnne Maas, Anne Westerweel, Heleen Maurice-Stam, et al.
The Journal of Pathology|January 22, 2009
The development of multiple bladder tumour recurrences in relation to the FGFR3 mutation status of the primary tumourLucie C Kompier, Madelon N M van der Aa, Irene Lurkin, et al.
Oncogene|November 17, 2005
Microsatellite instability and mutation analysis of candidate genes in urothelial cell carcinomas of upper urinary tractP Mongiat-Artus, C Miquel, M Van der Aa, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|September 22, 2006
Detection of HER2 amplification in breast carcinomas: comparison of Multiplex Ligation-dependent Probe Amplification (MLPA) and Fluorescence In Situ Hybridization (FISH) combined with automated spot countingElna Moerland, Rens L H P M van Hezik, Toine C J M van der Aa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urineJohanna M M van Oers, Irene Lurkin, Antonius J A van Exsel, et al.
Human Pathology|September 13, 2005
A new system for substaging pT1 papillary bladder cancer: a prognostic evaluationMadelon N M van der Aa, Geert J L H van Leenders, Ewout W Steyerberg, et al.
BJU International|June 9, 2009
Non-muscle-invasive bladder cancer surveillance for which cystoscopy is partly replaced by microsatellite analysis of urine: a cost-effective alternative?Esther W de Bekker-Grob, Madelon N M van der Aa, Ellen C Zwarthoff, et al.
BJU International|January 22, 2009
Sexual function of patients under surveillance for bladder cancerMadelon N M van der Aa, Milou D Bekker, Theo H van der Kwast, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2010
Fibroblast growth factor receptor 3 mutation analysis on voided urine for surveillance of patients with low-grade non-muscle-invasive bladder cancerTahlita C M Zuiverloon, Madelon N M van der Aa, Theo H van der Kwast, et al.
BJU International|September 25, 2007
Patients' perceived burden of cystoscopic and urinary surveillance of bladder cancer: a randomized comparisonMadelon N M van der Aa, Ewout W Steyerberg, E Fatma Sen, et al.
Psycho-Oncology|February 13, 2025
The Prevalence and Associated Factors of Cancer-Related Worries in Adult Survivors of Childhood Cancer: A Systematic ReviewAnne Maas, Anne Westerweel, Heleen Maurice-Stam, et al.
The Journal of Pathology|January 22, 2009
The development of multiple bladder tumour recurrences in relation to the FGFR3 mutation status of the primary tumourLucie C Kompier, Madelon N M van der Aa, Irene Lurkin, et al.
Oncogene|November 17, 2005
Microsatellite instability and mutation analysis of candidate genes in urothelial cell carcinomas of upper urinary tractP Mongiat-Artus, C Miquel, M Van der Aa, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|September 22, 2006
Detection of HER2 amplification in breast carcinomas: comparison of Multiplex Ligation-dependent Probe Amplification (MLPA) and Fluorescence In Situ Hybridization (FISH) combined with automated spot countingElna Moerland, Rens L H P M van Hezik, Toine C J M van der Aa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
A simple and fast method for the simultaneous detection of nine fibroblast growth factor receptor 3 mutations in bladder cancer and voided urineJohanna M M van Oers, Irene Lurkin, Antonius J A van Exsel, et al.
Human Pathology|September 13, 2005
A new system for substaging pT1 papillary bladder cancer: a prognostic evaluationMadelon N M van der Aa, Geert J L H van Leenders, Ewout W Steyerberg, et al.
BJU International|June 9, 2009
Non-muscle-invasive bladder cancer surveillance for which cystoscopy is partly replaced by microsatellite analysis of urine: a cost-effective alternative?Esther W de Bekker-Grob, Madelon N M van der Aa, Ellen C Zwarthoff, et al.
BJU International|January 22, 2009
Sexual function of patients under surveillance for bladder cancerMadelon N M van der Aa, Milou D Bekker, Theo H van der Kwast, et al.
Pageof 6